Skip to content
Agentic 10-K

Raphael Pharmaceutical Inc.RAPH

AI agent disclosures in SEC filings

As of 2026-09-01, Raphael Pharmaceutical Inc. (RAPH) disclosed AI-agent language in 1 SEC filing since 2026-09-01 (source: Agentic 10-K, from SEC EDGAR).

Market cap
$28MYahoo Finance, 2026-10-21
First seen
2026-09-01
Latest filing
2026-09-01

Matching filings by quarter

012Q1 '25Q2Q3Q4Q1 '26Q21Q3Q4*
Filings* Quarter in progress

What the filings cover

Functions named

Legal & compliance

Vendors and products named

None named

Source

1 filing since 2025-01-01. All EDGAR filings (opens in a new tab)

Stage and function are keyword-rule labels, not the company’s words.

In its own words

Sentences copied from the filings, whitespace normalised.

“Specialized AI agents for research, content, social, CRM, partnerships, product intelligence, analytics, web/app, and compliance flagging.”

8-KFiled 2026-09-01Source on sec.gov (opens in a new tab)Filing index (opens in a new tab)

All matching filings

8-K filed 2026-09-01 Filing index (opens in a new tab)

8-K, EX-10.1Filed 2026-09-01

Raphael Pharmaceutical lists specialized AI agents for various functions including research, content, CRM and compliance.

“Specialized AI agents for research, content, social, CRM, partnerships, product intelligence, analytics, web/app, and compliance flagging.”